Reduced incidence of septic arthritis in children by Haemophilus influenzae type-b vaccination -: Implications for treatment

被引:32
作者
Peltola, H
Kallio, MJT
Unkila-Kallio, L
机构
[1] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, FIN-00290 Helsinki, Finland
[2] Univ Helsinki, Dept Obstet & Gynecol 1, FIN-00290 Helsinki, Finland
[3] Univ Helsinki, Dept Obstet & Gynecol 2, FIN-00290 Helsinki, Finland
来源
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 1998年 / 80B卷 / 03期
关键词
D O I
10.1302/0301-620X.80B3.8296
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
In many countries Haemophilus influenzae type b (Hib) is the second most common cause of septic arthritis in children, In Finland large-scale immunisation against Hib using conjugate vaccines began in 1986, four years after a multicentre prospective study of orthopaedic infections in children had started. Since 1982, including six years before and ten after starting routine Hib vaccination, there has been a major change in the pattern of septic arthritis. From 1982 to 1988, 32 of 61 cases (53%) were caused by staphylococci, 22 (36%) by Hib and 7 (11%) by other bacteria. Since 1988, Hib infection has disappeared, and one-third of cases of childhood septic arthritis has been eliminated. This change has allowed us to reduce initial antimicrobial therapy for such children to cover only Gram-positive cocci, The more limited treatment is safer, reduces cost, and simplifies treatment.
引用
收藏
页码:471 / 473
页数:3
相关论文
共 27 条
[1]   ANTIBODY-RESPONSES TO HEMOPHILUS-INFLUENZAE TYPE B AND DIPHTHERIA-TOXIN INDUCED BY CONJUGATES OF OLIGOSACCHARIDES OF THE TYPE-B CAPSULE WITH THE NONTOXIC PROTEIN CRM197 [J].
ANDERSON, P .
INFECTION AND IMMUNITY, 1983, 39 (01) :233-238
[2]  
ARAMBULO RR, 1997, REV PARAGUAYA INFE S, V2, P30
[3]  
BOS E, 1994, P WORLD BANK
[4]   FURTHER-STUDIES ON THE IMMUNOGENICITY OF HEMOPHILUS-INFLUENZAE TYPE-B AND PNEUMOCOCCAL TYPE-6A POLYSACCHARIDE-PROTEIN CONJUGATES [J].
CHU, CY ;
SCHNEERSON, R ;
ROBBINS, JB ;
RASTOGI, SC .
INFECTION AND IMMUNITY, 1983, 40 (01) :245-256
[5]   SYSTEMIC HEMOPHILUS-INFLUENZAE DISEASE - OVERVIEW [J].
DAJANI, AS ;
ASMAR, BI ;
THIRUMOORTHI, MC .
JOURNAL OF PEDIATRICS, 1979, 94 (03) :355-364
[6]   COMPARATIVE TRIAL IN INFANTS OF 4 CONJUGATE HAEMOPHILUS-INFLUENZAE TYPE-B VACCINES [J].
DECKER, MD ;
EDWARDS, KM ;
BRADLEY, R ;
PALMER, P .
JOURNAL OF PEDIATRICS, 1992, 120 (02) :184-189
[7]   EFFICACY OF HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE VACCINE IN INFANCY [J].
ESKOLA, J ;
PELTOLA, H ;
TAKALA, AK ;
KAYHTY, H ;
HAKULINEN, M ;
KARANKO, V ;
KELA, E ;
REKOLA, P ;
RONNBERG, PR ;
SAMUELSON, JS ;
GORDON, LK ;
MAKELA, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (12) :717-722
[8]  
GLORION C, 1993, REV CHIR ORTHOP, V79, P650
[9]  
GORDON LK, 1984, MODERN APPROACHES VA, P393
[10]   THE EPIDEMIOLOGY OF INVASIVE HAEMOPHILUS-INFLUENZAE INFECTIONS IN CHILDREN UNDER 5 YEARS OF AGE IN THE NORTHERN TERRITORY - A 3-YEAR STUDY [J].
HANNA, JN .
MEDICAL JOURNAL OF AUSTRALIA, 1990, 152 (05) :234-+